Statement of the problem.

The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) study poses 2 questions. Of the options in treating the hyperglycemia of type 2 diabetes mellitus, which, if either, would be best for decreasing the likelihood of death or a serious cardiovascular disease event such as a heart attack: correcting the relative insulin deficiency or reducing insulin resistance? Do individuals with diabetes whose coronary disease can be managed medically have a better outcome with initial medical or interventional (percutaneous intervention or coronary artery bypass grafting) treatment? This article outlines the reasons for asking these questions.
AuthorsGeorge Steiner,
JournalThe American journal of cardiology (Am J Cardiol) Vol. 97 Issue 12A Pg. 3G-8G (Jun 19 2006) ISSN: 0002-9149 [Print] United States
PMID16813733 (Publication Type: Journal Article)
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Bypass
  • Coronary Artery Disease (complications, therapy)
  • Diabetes Mellitus, Type 1 (complications, therapy)
  • Humans
  • Myocardial Revascularization
  • Randomized Controlled Trials as Topic
  • Research Design

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: